Biological Age Reversal

Get younger.
Or don't pay.

Reverion is the first longevity program with outcome-guaranteed pricing. We combine quarterly biomarker panels, AI-personalized protocols, and continuous monitoring to measurably reverse your biological age.

Check My Biological Age → View Dashboard
2.6 years reversed per year on protocol
160+ biomarkers tracked quarterly
$0 if your biology doesn't improve

Longevity is broken.

The industry sells you tests you can't act on, supplements without evidence, and protocols designed for someone else's biology. You pay regardless of whether anything works.

Reverion is different. We don't sell hope. We sell measurable results, or we eat the cost.

The old model
  • Pay $15,000+ for diagnostics
  • Get a generic protocol
  • Hope it works
  • Pay again next year regardless
Reverion
  • Continuous biomarker monitoring
  • AI-personalized weekly protocols
  • Measurable biological age tracking
  • Pay only when results are proven

Your Biological Passport

Every member gets a living document of their biology. Not a snapshot, a continuous feed.

01

Deep Panel Biomarkers

Quarterly comprehensive testing: epigenetic clocks, telomere length, inflammatory markers, microbiome composition, VO2 max, hormone panels, and 150+ additional markers that establish your true biological age.

02

AI Intervention Engine

Your biomarkers, genetics, lifestyle data, sleep patterns, and stress signals are synthesized into a weekly-updated protocol. Peptides, nutrition timing, sleep optimization, hormone balancing, targeted exercise. Personalized to your biology, not a generic playbook.

03

Performance-Based Pricing

$500/month base. If your biological age drops 1 to 3 years in 12 months, a $5,000 success bonus. If it doesn't drop, 6 months free. We only win when you get younger.

04

The Network Effect

Every member's anonymized data makes the AI smarter. 100,000 members creates the world's largest longevity outcomes dataset. Your results improve everyone's. Everyone's results improve yours.

The science is ready.

$2.25B
Epigenetics market size in 2026, growing 15-17% annually
2026
First human trials for epigenetic reprogramming began this year
4:1
ROI demonstrated by outcome-based healthcare models
0
Longevity companies offering outcome-guaranteed pricing today

The longevity industry charges you to hope.
We charge you to prove.

Reverion exists because the gap between longevity science and longevity business is incentive alignment. When the company only profits from your measurable improvement, everything changes: the protocols get better, the monitoring gets tighter, the outcomes get real.

Your biology has a number. We move it backward.